Literature DB >> 28677759

Analysis of murine and human Treg subsets in inflammatory bowel disease.

Xiaoyun Sun1, Shaoheng He2, Changlong Lv1, Xun Sun1, Junling Wang2, Wenjiao Zheng2, Danan Wang1.   

Abstract

Previous studies have indicated that regulatory T cells serve essential roles in maintaining intestinal homeostasis, however, the role of different Treg subsets in modulating inflammatory bowel disease has still not been addressed clearly. In the present study, the authors measured the percentage of Foxp3+ IL‑10+ TGF‑β+ natural Tregs, Foxp3‑ IL‑10+ TGF‑β‑ induced Tregs, CD127‑ induced Tregs and CD8+ Tregs at different time points in DSS‑induced experimental colitis model in murine lamina propria lymphocytes, mesenteric lymph node and peripheral blood. In addition, the authors compared the frequency of four Treg subsets in patients diagnosed of ulcerative colitis at different stages with enrolled healthy controls. The percentage of Foxp3+ IL‑10+ TGF‑β+ natural Tregs decreased in acute stage of both human and mice was observed, but proliferated significantly during remittent stage. Foxp3‑ IL‑10+ TGF‑β‑ inducible (i) Treg and CD127‑ iTreg was observed as being significantly decreased percentage in LPL at 4 and 7 days, the frequency of Foxp3‑ IL‑10+ TGF‑β‑ iTreg cells became decreased and CD127‑ iTreg only slightly increased at the chronic stage following DSS induction. However, the proportion of both Foxp3‑ IL‑10+ TGF‑β‑ iTreg and CD127‑ iTreg was nearly unchanged in human IBD. Although intestinal inflammation decreased the percentage of CD8+ Tregs, it remained lower in the remittent stage of human IBD. Only enhanced proliferation of lamina propria lymphocytes‑derived CD8+ Treg was reported at 7 days in dextran sodium sulfate‑induced murine colitis. The results demonstrated that Foxp3+ IL‑10+ TGF‑β+ natural Tregs may serve an essential role in exhibiting suppressive and protecting from immune‑related mucosal injury during chronic stage in inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28677759     DOI: 10.3892/mmr.2017.6912

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  14 in total

1.  Impaired estrogen signaling underlies regulatory T cell loss-of-function in the chronically inflamed intestine.

Authors:  Wendy A Goodman; Sarah M Bedoyan; Hannah L Havran; Brian Richardson; Mark J Cameron; Theresa T Pizarro
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-06       Impact factor: 11.205

2.  Mass Cytometry and Single-Cell Transcriptome Analyses Reveal the Immune Cell Characteristics of Ulcerative Colitis.

Authors:  Yongxin Luo; Shiying Liu; Huibiao Li; Jiangtao Hou; Wenjia Lin; Zewen Xu; Tianyu Lu; Yanwu Li; Bin Peng; Shijing Zhang; Xue Han; Zuoliang Kuang; Yi Wen; Jiazhong Cai; Fengbin Liu; Xin-Lin Chen
Journal:  Front Mol Biosci       Date:  2022-06-23

3.  Methane Alleviates Lung Injury through the IL-10 Pathway by Increasing T Regulatory Cells in a Mouse Asthma Model.

Authors:  Ying Yao; Xiaoyong Miao; Liping Wang; Zhengyu Jiang; Lingxia Li; Ping Jiang; Yifei Wang; Aixia Jin; Na Li; Changli Wang; Kezhe Tan; Yan Meng; Jinjun Bian; Yan Zhang; Xiaoming Deng; Jianping Cao
Journal:  J Immunol Res       Date:  2022-06-30       Impact factor: 4.493

Review 4.  The Role of Gut Microbiota Biomodulators on Mucosal Immunity and Intestinal Inflammation.

Authors:  Chiara Amoroso; Federica Perillo; Francesco Strati; Massimo C Fantini; Flavio Caprioli; Federica Facciotti
Journal:  Cells       Date:  2020-05-16       Impact factor: 6.600

5.  Histone Deacetylases Enhance Ca2+-Activated K⁺ Channel KCa3.1 Expression in Murine Inflammatory CD4⁺ T Cells.

Authors:  Miki Matsui; Kyoko Terasawa; Junko Kajikuri; Hiroaki Kito; Kyoko Endo; Pattaporn Jaikhan; Takayoshi Suzuki; Susumu Ohya
Journal:  Int J Mol Sci       Date:  2018-09-27       Impact factor: 5.923

6.  Enhancement of Circulating and Intestinal T Regulatory Cells and Their Expression of Helios and Neuropilin-1 in Children with Inflammatory Bowel Disease.

Authors:  Katarzyna Sznurkowska; Justyna Luty; Ewa Bryl; Jacek M Witkowski; Blanka Hermann-Okoniewska; Piotr Landowski; Marta Kosek; Agnieszka Szlagatys-Sidorkiewicz
Journal:  J Inflamm Res       Date:  2020-11-26

Review 7.  CD38: An Immunomodulatory Molecule in Inflammation and Autoimmunity.

Authors:  Zayda L Piedra-Quintero; Zachary Wilson; Porfirio Nava; Mireia Guerau-de-Arellano
Journal:  Front Immunol       Date:  2020-11-30       Impact factor: 7.561

8.  IL-35 recombinant protein reverses inflammatory bowel disease and psoriasis through regulation of inflammatory cytokines and immune cells.

Authors:  Yuan Wang; Ying Mao; Junfeng Zhang; Gang Shi; Lin Cheng; Yi Lin; Yiming Li; Xiaomei Zhang; Yujing Zhang; Xiaolei Chen; Jie Deng; Xiaolan Su; Lei Dai; Yang Yang; Shuang Zhang; Dechao Yu; Yuquan Wei; Hongxin Deng
Journal:  J Cell Mol Med       Date:  2017-11-29       Impact factor: 5.310

9.  The Prophylactic Use of Bovine Colostrum in a Murine Model of TNBS-Induced Colitis.

Authors:  Laura Menchetti; Giulio Curone; Iulia Elena Filipescu; Olimpia Barbato; Leonardo Leonardi; Gabriella Guelfi; Giovanna Traina; Patrizia Casagrande-Proietti; Federica Riva; Anna Beatrice Casano; Federica Piro; Daniele Vigo; Alda Quattrone; Gabriele Brecchia
Journal:  Animals (Basel)       Date:  2020-03-15       Impact factor: 2.752

Review 10.  Nucleic Acid-Based Approaches for Tumor Therapy.

Authors:  Simone Hager; Frederic Julien Fittler; Ernst Wagner; Matthias Bros
Journal:  Cells       Date:  2020-09-09       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.